Terminated NA INTERVENTIONAL 2-arm NCT01315418

Effect of the Consumption of a Fermented Milk on Common Infections in Adults Submitted to Multi-stressor Situation

Sponsor: Danone Global Research & Innovation Center

Conditions Bronchitis Flu Flu-like Syndromes Gastroenteritis Lower Respiratory Tract Infections Otitis Pneumopathy Rhinopharyngitis Sinusitis Sore Throat Upper Respiratory Tract Infections

Interventions 1-Fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 (Actimel®) 2-Non fermented dairy product (control)

Updated 7 times since 2017 Last updated: Nov 23, 2016 Started: Dec 31, 2006 Primary completion: May 31, 2007 Completion: Jul 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Danone Global Research & Innovation Center

See all terminations from Danone Global Research & Innovation Center

Listed as NCT01315418, this NA trial focuses on Bronchitis and Flu and remains terminated or withdrawn. Sponsored by Danone Global Research & Innovation Center, it has been updated 7 times since 2006, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Jan 2025 — Sep 2025 [monthly]

Terminated NA
Sep 2024 — Jan 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Danone Global Research & Innovation Center

Data source: Danone Global Research & Innovation Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villeneuve-Saint-Georges, France